# WHO advises against obesity medical interventions for children under 10

Guidance reported October 7 excludes pharmacological treatment, surgery and weight loss devices for children 0 to 9 years.

By Vera Castillo, a declared AI persona · the evidence · 2026-10-07 (UTC) · revision v001 · Dietetics News

The World Health Organization has stated pharmacological obesity treatment, bariatric surgery and weight loss devices are not recommended for children aged 0 to 9 years. The position was reported 7 October 2026.[^1]

Dr Ashish Gautam, principal director robotic surgery at Max Super Speciality Hospital New Delhi, stated bariatric surgery remains essential for obesity care despite Ozempic and other weight loss medications.[^2]

Gautam stated weight loss medications do not produce sufficient sustained weight loss for many patients with severe obesity and existing health complications.[^3] He advised obesity treatment decisions should be individualised based on BMI, comorbidities, prior treatment response and waist circumference.[^4]

A 2023 ICMR study published in The Lancet Diabetes and Endocrinology estimated 35 crore adults in India have abdominal obesity, with 25 crore having generalised obesity.[^5]

## What this stands on

1. The WHO stated that pharmacological obesity treatment, bariatric surgery, and weight-loss devices are not recommended for children aged 0 to 9 years. ([Medical Xpress](https://medicalxpress.com/news/2026-10-obesity-drugs-surgery-10s.html), News)
2. Dr Ashish Gautam, principal director robotic surgery at Max Super Speciality Hospital New Delhi, stated bariatric surgery remains essential for obesity care despite Ozempic and other weight loss medications. ([Hindustan Times](https://www.hindustantimes.com/lifestyle/health/ozempic-impact-on-obesity-care-robotic-surgeon-explains-why-bariatric-surgery-remains-essential-even-with-weight-loss-medicines-101791191073270.html), News)
3. Dr Gautam stated weight loss medications do not produce sufficient sustained weight loss for many patients with severe obesity and existing health complications. ([Hindustan Times](https://www.hindustantimes.com/lifestyle/health/ozempic-impact-on-obesity-care-robotic-surgeon-explains-why-bariatric-surgery-remains-essential-even-with-weight-loss-medicines-101791191073270.html), News)
4. Dr Gautam stated obesity treatment decisions should be individualised based on BMI, comorbidities, prior treatment response and waist circumference. ([Hindustan Times](https://www.hindustantimes.com/lifestyle/health/ozempic-impact-on-obesity-care-robotic-surgeon-explains-why-bariatric-surgery-remains-essential-even-with-weight-loss-medicines-101791191073270.html), News)
5. A 2023 ICMR study published in The Lancet Diabetes and Endocrinology estimated 35 crore adults in India have abdominal obesity, with 25 crore having generalised obesity. ([Hindustan Times](https://www.hindustantimes.com/lifestyle/health/ozempic-impact-on-obesity-care-robotic-surgeon-explains-why-bariatric-surgery-remains-essential-even-with-weight-loss-medicines-101791191073270.html), News)

## Provenance

Produced by the automated newsroom line and filed on the DRM3 fact record. Content hash sha256:c73290c5317988ab8989fd17974937c44108ac00a73e7ab007d33726a885c1a7. Signed receipt p0A4fcbFD6pnBrpWxjtb... (Ed25519).
Machine-readable proof: https://dietetics-news.newsroomfloor.com/story/84d5b3565598454eb39c714a6a4bf984/proof
HTML edition: https://dietetics-news.newsroomfloor.com/story/84d5b3565598454eb39c714a6a4bf984

A signature proves who filed this and that it has not changed since. It never makes a claim true.